ImmunotherapyLeukemiaLymphomaPersonalized MedicineTelling Patients About CAR T-Cell Therapy
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
Video Library – March 6, 2019 The Children's Hospital of Philadelphia, Philadelphia, PA
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
Recommended For You
Breast CancerImmunotherapyRecently, Tecentriq became the first immunotherapy to be approved for the treatment of patients with metastatic triple-negative breast cancer, a particularly difficult type of breast cancer.
LeukemiaAt the June 2019 annual meeting of the American Society of Clinical Oncology (ASCO), 2 experts discussed the implications of new treatments for chronic lymphocytic leukemia (CLL). The blood cancer known as CLL is often diagnosed late, and until recently the initial treatment was chemotherapy alone. However, new non-chemotherapy targeted therapies have been approved by the FDA in the past few months for use as the first (or first-line) treatment for patients with CLL.
Breast CancerImmunotherapyTriple-negative breast cancer is an aggressive type of cancer that usually has a high rate of disease recurrence (returning) within the first 5 years after diagnosis.
ImmunotherapyThe immune system attacks foreign substances by making large numbers of antibodies. These are proteins that attach to a specific protein on the cell called an antigen.
Last modified: March 25, 2019
